<DOC>
	<DOC>NCT01357174</DOC>
	<brief_summary>This study will collect demographic and safety information on the use of ROTATEQ™ in the Philippines.</brief_summary>
	<brief_title>ROTATEQ™ Post-Marketing Surveillance in the Philippines</brief_title>
	<detailed_description />
	<mesh_term>Gastroenteritis</mesh_term>
	<mesh_term>Rotavirus Infections</mesh_term>
	<criteria>Received ROTATEQ™</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>12 Weeks</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>